Ambu A/S/DKr AMBU B
07:00
09:00
11:00
12:55
14:55
1D1W1MYTD1Y5YMAX
About Ambu A/S
Ambu A/S is a Danish company operating in the medical device industry, focusing on the development and marketing of products for hospitals and healthcare providers. The company specializes in anesthesiology, patient monitoring and diagnostics, and emergency care solutions. Some of Ambu's key products include single-use endoscopes, resuscitators, and electrodes for patient monitoring. Founded in 1937, Ambu is headquartered in Ballerup, Denmark, and serves a global market with a significant presence in Europe, North America, and Asia. The company is known for its strategic emphasis on innovation in single-use devices, which helps reduce the risk of cross-contamination and improves healthcare efficiency.
Ticker
DKr AMBU B
Sector
Primary listing
CSE
Employees
5,200
Headquarters
Ballerup, Denmark
Website
Ambu A/S Metrics
BasicAdvanced
kr 17bn
35.08
kr 1.79
1.26
kr 0.41
0.65%
Price and volume
Market cap
kr 17bn
Beta
1.26
52-week high
kr 111.80
52-week low
kr 60.45
Average daily volume
1m
Dividend rate
kr 0.41
Financial strength
Current ratio
2.92
Quick ratio
1.618
Long term debt to equity
7.638
Total debt to equity
9.031
Dividend payout ratio (TTM)
23.06%
Interest coverage (TTM)
19.24%
Profitability
EBITDA (TTM)
811
Gross margin (TTM)
59.98%
Net profit margin (TTM)
7.81%
Operating margin (TTM)
10.71%
Effective tax rate (TTM)
23.06%
Revenue per employee (TTM)
kr 1,170,000
Management effectiveness
Return on assets (TTM)
5.44%
Return on equity (TTM)
7.94%
Valuation
Price to earnings (TTM)
35.081
Price to revenue (TTM)
2.735
Price to book
2.7
Price to tangible book (TTM)
5.9
Price to free cash flow (TTM)
44.513
Free cash flow yield (TTM)
2.25%
Free cash flow per share (TTM)
1.411
Dividend yield (TTM)
0.65%
Forward dividend yield
0.65%
Growth
Revenue change (TTM)
4.63%
Earnings per share change (TTM)
29.57%
3-year revenue growth (CAGR)
9.79%
10-year revenue growth (CAGR)
11.74%
3-year earnings per share growth (CAGR)
90.42%
10-year earnings per share growth (CAGR)
10.18%
10-year dividend per share growth (CAGR)
7.99%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs